EXECUTIVE DIRECTOR, GLOBAL VALUE, ACCESS AND POLICY, BIOSIMILARS, AMGEN
Thousand Oaks, California, United States
As Executive Director, Global Value Access and Policy for Amgen’s Biosimilars Business Unit, Chad Pettit develops global market access launch strategy for Amgen’s portfolio of 10 biosimilar medicines and leads across the biopharmaceutical industry on biosimilar policy matters, in a new and rapidly growing segment of the industry and growth business for Amgen. Chad speaks frequently as an expert on biosimilar commercialization and market access for biosimilar medicines.
Biologics have revolutionized treatment for serious diseases and profoundly impacted millions of…